Heuvelmans MA[au] - Search Results

Year	Number of Results
2013	5
2014	5
2015	3
2016	2
2017	9
2018	11
2019	8
2020	12
2021	8
2022	1

1

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. de Koning HJ, et al. Among authors: heuvelmans ma. N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995683 Clinical Trial.

2

Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Oudkerk M, Liu S, Heuvelmans MA, Walter JE, Field JK. Oudkerk M, et al. Among authors: heuvelmans ma. Nat Rev Clin Oncol. 2021 Mar;18(3):135-151. doi: 10.1038/s41571-020-00432-6. Epub 2020 Oct 12. Nat Rev Clin Oncol. 2021. PMID: 33046839 Review.

3

European position statement on lung cancer screening.

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK. Oudkerk M, et al. Among authors: heuvelmans ma. Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6. Lancet Oncol. 2017. PMID: 29208441 Review.

4

Response.

Heuvelmans MA, Oudkerk M, Vliegenthart R. Heuvelmans MA, et al. Radiology. 2014 Apr;271(1):311. Radiology. 2014. PMID: 24795985 No abstract available.

5

Appropriate screening intervals in low-dose CT lung cancer screening.

Heuvelmans MA, Oudkerk M. Heuvelmans MA, et al. Transl Lung Cancer Res. 2018 Jun;7(3):281-287. doi: 10.21037/tlcr.2018.05.08. Transl Lung Cancer Res. 2018. PMID: 30050766 Free PMC article. Review.

6

Early lung cancer detection by low-dose CT screening: therapeutic implications.

Heuvelmans MA, Groen HJ, Oudkerk M. Heuvelmans MA, et al. Expert Rev Respir Med. 2017 Feb;11(2):89-100. doi: 10.1080/17476348.2017.1276445. Epub 2016 Dec 30. Expert Rev Respir Med. 2017. PMID: 28005439 Review.

7

An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.

Han D, Heuvelmans MA, Vliegenthart R, Rook M, Dorrius MD, Oudkerk M. Han D, et al. Among authors: heuvelmans ma. J Thorac Imaging. 2019 Jan;34(1):65-71. doi: 10.1097/RTI.0000000000000367. J Thorac Imaging. 2019. PMID: 30325795 Review.

8

Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening.

Han D, Heuvelmans MA, Oudkerk M. Han D, et al. Among authors: heuvelmans ma. Transl Lung Cancer Res. 2017 Feb;6(1):52-61. doi: 10.21037/tlcr.2017.01.05. Transl Lung Cancer Res. 2017. PMID: 28331824 Free PMC article. Review.

9

Management of baseline and new sub-solid nodules in CT lung cancer screening.

Heuvelmans MA, Walter JE, Oudkerk M. Heuvelmans MA, et al. Expert Rev Respir Med. 2018 Jan;12(1):1-3. doi: 10.1080/17476348.2018.1398087. Epub 2017 Nov 1. Expert Rev Respir Med. 2018. PMID: 29082801 No abstract available.

10

A practical approach to radiological evaluation of CT lung cancer screening examinations.

Xie X, Heuvelmans MA, van Ooijen PM, Oudkerk M, Vliegenthart R. Xie X, et al. Among authors: heuvelmans ma. Cancer Imaging. 2013 Sep 23;13(3):391-9. doi: 10.1102/1470-7330.2013.9043. Cancer Imaging. 2013. PMID: 24061210 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results